Cost-effectiveness of stereotactic laser ablation (SLA) for brain tumors.
CONCLUSION: There is limited data on the cost-effectiveness of SLA. In the available literature, SLA compared favorably to craniotomy in terms of cost-effectiveness as a treatment for primary and metastatic brain cancers.
PMID: 32672125 [PubMed - in process]
Source: International Journal of Hyperthermia - Category: Internal Medicine Tags: Int J Hyperthermia Source Type: research
More News: Brain | Brain Cancers | Brain Tumor | Cancer | Cancer & Oncology | Craniotomy | Databases & Libraries | Glioma | Internal Medicine | Neurology | Nurses | Nursing | Rehabilitation | Study